COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome

Erik Boot*, Jan Booij, Janneke R. Zinkstok, Frank Baas, Ann Swillen, Michael J. Owen, Declan G. Murphy, Kieran C. Murphy, Don H. Linszen, Thérèse A. Van Amelsvoort

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

11 Citations (Scopus)

Abstract

Although catechol-O-methyltransferase (COMT) activity evidently affects dopamine function in prefrontal cortex, the contribution is assumed less significant in striatum. We studied whether a functional polymorphism in the COMT gene (Val158Met) influences striatal D2/3R binding ratios (D2/3R BPND) in 15 adults with 22q11 deletion syndrome and hemizygous for this gene, using single photon emission computed tomography and the selective D2/3 radioligand [123I]IBZM. Met hemizygotes had significantly lower mean D2/3R BPND than Val hemizygotes. These preliminary data suggest that low COMT activity may affect dopamine levels in striatum in humans and this may have implications for understanding the contribution of COMT activity to psychiatric disorders.

Original languageEnglish
Pages (from-to)967-970
Number of pages4
JournalSynapse
Volume65
Issue number9
DOIs
Publication statusPublished - 1 Sept 2011
Externally publishedYes

Keywords

  • Catechol-O-methyltransferase
  • D receptor binding
  • Dopamine
  • SPECT
  • Striatum

Fingerprint

Dive into the research topics of 'COMT Val158met genotype and striatal D2/3 receptor binding in adults with 22q11 deletion syndrome'. Together they form a unique fingerprint.

Cite this